2010
DOI: 10.1016/j.jacc.2010.04.014
|View full text |Cite
|
Sign up to set email alerts
|

ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
7

Year Published

2011
2011
2017
2017

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 75 publications
(27 citation statements)
references
References 135 publications
0
20
0
7
Order By: Relevance
“…The study population consisted of 23 patients with HF and end-stage DCM ( n  = 11) or ICM ( n  = 12) eligible for and undergoing heart transplantation (HT) according to recent guidelines [15]. Patients with arterial hypertension, recent myocardial infarction (≤6 months before surgery) or myocarditis, diabetes or evidence of valve disease were excluded from the study.…”
Section: Methodsmentioning
confidence: 99%
“…The study population consisted of 23 patients with HF and end-stage DCM ( n  = 11) or ICM ( n  = 12) eligible for and undergoing heart transplantation (HT) according to recent guidelines [15]. Patients with arterial hypertension, recent myocardial infarction (≤6 months before surgery) or myocarditis, diabetes or evidence of valve disease were excluded from the study.…”
Section: Methodsmentioning
confidence: 99%
“…Some patients may require short-term bridging with inotropes and inhaled nitric oxide to provide optimal medical support to both ventricles after device explantation. The patient should also be treated with neurohormonal blockade, as recommended by the American College of Cardiology Foundation/American Heart Association heart failure guidelines, 14 once pressors are no longer needed. Dr Uriel: Although there is a large body of evidence supporting internal cardioverter-defibrillator placement in chronic cardiomyopathy, 15 there are minimal data on patients with preserved ejection fraction with myocarditis who have ventricular arrhythmias during the recovery period.…”
Section: 10mentioning
confidence: 99%
“…124 Table 4 shows the treatment schedule for diastolic HF. 13,30,34,46,48 As yet, no treatment has been shown conclusively to reduce morbidity and mortality in HF patients with preserved LVEF. Diuretics are used to control sodium and water retention and reduce dyspnoea and oedema, as in HF with depressed LVEF.…”
Section: Alpha-2 Agonistsmentioning
confidence: 99%